Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Robust predictors for drug response of patients with acute myeloid leukemia
Saved in:
| Published in: | PLOS ONE |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Robust predictors for drug response of patients with acute myeloid leukemia
- Solamargine induces acute myeloid leukemia differentiation through TLR8 activation
- Comprehensive analysis of the potential effect and mechanism of pyroptosis-related genes in treatment-related myeloid tumors
- Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression
- Aplastic Anemia induced by Nivolumab before a Treatment of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
- Optimal minimal residual disease threshold in pediatric acute myeloid leukemia: A retrospective cohort study based on the TARGET database
- Evaluating the impact of a rapid response system on survival of patients with cancer undergoing emergency surgery for acute abdomen: A single-center retrospective cohort study